Pharmacy Society of Wisconsin
Registered Principal Details
Business Or Interest:
Pharmacy, heath care
Lobbying Interests:
Pharmacy, health care
CEO Name:
Christopher Decker
Director of Public Affairs
Pharmacy, heath care
Lobbying Interests:
Pharmacy, health care
CEO Name:
Christopher Decker
Director of Public Affairs
Contact
DML
Danielle M Laurent
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dlaurent@pswi.org
http://www.pswi.org
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dlaurent@pswi.org
http://www.pswi.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 15
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)
Bill Text and History
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)
Bill Text and History
For
Notification Date2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 96
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
Bill Text and History
5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
Bill Text and History
For
Notification Date5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 203
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
For
Notification Date5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 311
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
Bill Text and History
9/2/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
Bill Text and History
Other
Notification Date9/2/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 312
Relating to: limitations on requiring vaccination against influenza.
Bill Text and History
9/22/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: limitations on requiring vaccination against influenza.
Bill Text and History
Against
Notification Date9/22/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 364
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
Bill Text and History
2015 Wisconsin Act 266
10/12/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
Bill Text and History
2015 Wisconsin Act 266
Other
Notification Date10/12/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 427
Relating to: prescription, dispensing, and delivery of opioid antagonists.
Bill Text and History
2015 Wisconsin Act 115
10/30/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescription, dispensing, and delivery of opioid antagonists.
Bill Text and History
2015 Wisconsin Act 115
For
Notification Date10/30/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 452
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
Bill Text and History
12/15/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
Bill Text and History
Against
Notification Date12/15/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 841
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
Bill Text and History
2015 Wisconsin Act 313
2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
Bill Text and History
2015 Wisconsin Act 313
For
Notification Date2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 865
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
Bill Text and History
2015 Wisconsin Act 290
2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
Bill Text and History
2015 Wisconsin Act 290
For
Notification Date2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 866
Relating to: prescription refills.
Bill Text and History
2015 Wisconsin Act 291
2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescription refills.
Bill Text and History
2015 Wisconsin Act 291
For
Notification Date2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 13
Relating to: licensure of home medical oxygen providers, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
Bill Text and History
2015 Wisconsin Act 3
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: licensure of home medical oxygen providers, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
Bill Text and History
2015 Wisconsin Act 3
Other
Notification Date2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 15
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)
Bill Text and History
2015 Wisconsin Act 43
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)
Bill Text and History
2015 Wisconsin Act 43
For
Notification Date2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 74
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
Bill Text and History
2015 Wisconsin Act 34
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
Bill Text and History
2015 Wisconsin Act 34
For
Notification Date3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 139
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
2015 Wisconsin Act 35
5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
2015 Wisconsin Act 35
For
Notification Date5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 218
Relating to: limitations on requiring vaccination against influenza.
Bill Text and History
9/22/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: limitations on requiring vaccination against influenza.
Bill Text and History
Against
Notification Date9/22/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 238
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
Bill Text and History
2015 Wisconsin Act 152
9/2/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
Bill Text and History
2015 Wisconsin Act 152
Other
Notification Date9/2/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 268
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
Bill Text and History
10/12/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
Bill Text and History
Other
Notification Date10/12/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 345
Relating to: prescription, dispensing, and delivery of opioid antagonists.
Bill Text and History
10/30/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescription, dispensing, and delivery of opioid antagonists.
Bill Text and History
For
Notification Date10/30/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 371
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
Bill Text and History
12/15/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
Bill Text and History
Against
Notification Date12/15/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 708
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
Bill Text and History
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
Bill Text and History
For
Notification Date7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 709
Relating to: prescription refills.
Bill Text and History
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescription refills.
Bill Text and History
For
Notification Date7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 743
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
Bill Text and History
2/24/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
Bill Text and History
For
Notification Date2/24/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Employee Trust Funds
Employee Trust Funds
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance - General
Health Services: Medical Assistance - General
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Public Health and Other Programs
Health Services: Public Health and Other Programs
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Agencywide Provisions
Safety and Professional Services: Agencywide Provisions
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Program Transfers
Safety and Professional Services: Program Transfers
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Administrative Rulemaking Proceedings
Agency Name
Controlled Substances Board (CSB)
Subject
Operation of the Prescription Drug Monitoring Program
Scope Statement
SS 103_15
2/1/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Controlled Substances Board (CSB)
Subject
Operation of the Prescription Drug Monitoring Program
Scope Statement
SS 103_15
None
Notification Date2/1/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Administration of drug products and devices other than vaccines
Scope Statement
SS 032_16
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Administration of drug products and devices other than vaccines
Scope Statement
SS 032_16
For
Notification Date7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Application and examination for pharmacists. SS 089-14
Scope Statement
Register Number: 705 (9/15/2014)
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Application and examination for pharmacists. SS 089-14
Scope Statement
Register Number: 705 (9/15/2014)
Other
Notification Date3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
Other
Notification Date7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Scope Statement
Register Number: 683 (11/15/2012)
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Scope Statement
Register Number: 683 (11/15/2012)
Other
Notification Date7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Revises Chapters Phar 1, 8, and 18, relating to definitions, controlled substances and the operation of the Prescription Drug Monitoring Program (PDMP). SS 106-14
Agency Name
Pharmacy Examining Board (Phar)
Subject
Revises Chapters Phar 1, 8, and 18, relating to definitions, controlled substances and the operation of the Prescription Drug Monitoring Program (PDMP). SS 106-14
Scope Statement
Register Number: 706 (10/15/2014)
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Revises Chapters Phar 1, 8, and 18, relating to definitions, controlled substances and the operation of the Prescription Drug Monitoring Program (PDMP). SS 106-14
Scope Statement
Register Number: 706 (10/15/2014)
Other
Notification Date3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Revises Chapters Phar 8 and 18, relating to recording name of person presenting ID and providing data to the prescription drug monitoring program. SS 105-14
Agency Name
Pharmacy Examining Board (Phar)
Subject
Revises Chapters Phar 8 and 18, relating to recording name of person presenting ID and providing data to the prescription drug monitoring program. SS 105-14
Scope Statement
Register Number: 706 (10/15/2014)
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Revises Chapters Phar 8 and 18, relating to recording name of person presenting ID and providing data to the prescription drug monitoring program. SS 105-14
Scope Statement
Register Number: 706 (10/15/2014)
Other
Notification Date3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Pharmacy Administrative Code
Pharmacy Administrative Code
Action Intended To Affect
Rule (by a state agency)
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Rule (by a state agency)
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
administration of nonvaccine injections
administration of nonvaccine injections
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
pharmacy benefit managers
pharmacy benefit managers
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters relating to pharmacy networks and specialty pharmacy networks
Matters relating to pharmacy networks and specialty pharmacy networks
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/28/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/28/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to pharmacist delivery of services
Matters related to pharmacist delivery of services
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to medication management and optimization
Matters related to medication management and optimization
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Medicaid reimbursement and audits
Medicaid reimbursement and audits
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to pharmacy and pharmacist regulation
Matters related to pharmacy and pharmacist regulation
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to immunization services and reimbursement
Matters related to immunization services and reimbursement
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to pharmacy audits
Matters related to pharmacy audits
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to pharmacy reimbursement
Matters related to pharmacy reimbursement
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2015 January - June $23,178.20 |
2015 July - December $45,990.31 |
2016 January - June $56,926.04 |
2016 July - December $44,596.22 |
Total $170,690.78 |
| Total Hours Communicating | 2015 January - June 217.25 |
2015 July - December 84.00 |
2016 January - June 167.70 |
2016 July - December 115.50 |
Total 584.45 |
| Total Hours Other | 2015 January - June 684.50 |
2015 July - December 474.00 |
2016 January - June 520.75 |
2016 July - December 462.50 |
Total 2141.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 2% |
2015 July - December |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 2% |
2015 July - December 2% |
2016 January - June |
2016 July - December |
Total 1% |
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 2% |
2015 July - December 1% |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: licensure of home medical oxygen providers, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 3% |
2015 July - December |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 1% |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: limitations on requiring vaccination against influenza.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 1% |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 2% |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 2% |
2016 January - June 3% |
2016 July - December |
Total 1% |
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 3% |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 3% |
2016 January - June |
2016 July - December |
Total < 1% |
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 5% |
2016 January - June |
2016 July - December |
Total 1% |
Relating to: prescription, dispensing, and delivery of opioid antagonists.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 5% |
2016 January - June |
2016 July - December |
Total 1% |
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 5% |
2016 January - June |
2016 July - December |
Total 1% |
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 10% |
2016 January - June 3% |
2016 July - December |
Total 3% |
Relating to: prescription, dispensing, and delivery of opioid antagonists.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 15% |
2016 January - June |
2016 July - December |
Total 3% |
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 5% |
2016 July - December |
Total 1% |
Relating to: prescription refills.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 5% |
2016 July - December |
Total 1% |
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 5% |
2016 July - December |
Total 1% |
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 15% |
2016 July - December |
Total 4% |
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 15% |
2016 July - December |
Total 4% |
Relating to: prescription refills.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 15% |
2016 July - December |
Total 4% |
Budget Bill Subjects
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 1% |
2015 July - December |
2016 January - June |
2016 July - December |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 4% |
2015 July - December |
2016 January - June |
2016 July - December |
Total 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 20% |
2015 July - December |
2016 January - June |
2016 July - December |
Total 7% |
Administrative Rulemaking Proceedings
Revises Chapters Phar 8 and 18, relating to recording name of person presenting ID and providing data to the prescription drug monitoring program. SS 105-14
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 2% |
2015 July - December 10% |
2016 January - June |
2016 July - December |
Total 3% |
Revises Chapters Phar 1, 8, and 18, relating to definitions, controlled substances and the operation of the Prescription Drug Monitoring Program (PDMP). SS 106-14
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December 2% |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 25% |
2016 January - June 3% |
2016 July - December 10% |
Total 8% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 5% |
2016 July - December 15% |
Total 4% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December 5% |
Total 1% |
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 20% |
2016 July - December 10% |
Total 7% |
Topics Not Yet Assigned A Bill Or Rule Number
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 1% |
2015 July - December 8% |
2016 January - June |
2016 July - December |
Total 2% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 2% |
2015 July - December |
2016 January - June |
2016 July - December |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 3% |
2015 July - December |
2016 January - June |
2016 July - December |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 3% |
2015 July - December |
2016 January - June |
2016 July - December |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 5% |
2015 July - December |
2016 January - June |
2016 July - December 3% |
Total 2% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 50% |
2015 July - December |
2016 January - June |
2016 July - December 7% |
Total 18% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 2% |
2016 January - June |
2016 July - December |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June 6% |
2016 July - December 30% |
Total 8% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December 3% |
Total < 1% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December 15% |
Total 3% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.